作者: Yu. A. Gracheva , A. Yu. Fedorov , E. S. Shchegravina , A. V. Nyuchev , A. A. Sachkova
DOI: 10.1134/S1068162021010222
关键词: Medicine 、 Drug delivery 、 Immunotherapy 、 Personalized medicine 、 Targeted drug delivery 、 In vivo 、 Clinical Practice 、 Bioinformatics
摘要: … were named siglecs (sialic acid-binding immunoglobulin-type lectins). Due to their expression patterns, endocytic properties and ability to perform receptor signaling modulation, siglecs …